Dr. Leventer received his dental degree from the University of Maryland in 1990. He then completed a General Practice Residency, and a Dental Anesthesiology Residency at Brookdale Hospital Medical Center in New York.

Dr. Leventer is a Diplomat of the American Dental Board of Anesthesiology where he is also on the Board of Directors and serves as a board examiner.  He is a member of the American Society of Dentist Anesthesiologists, the Academy of General Dentistry and the American Dental Association. Dr. Leventer is committed to providing dental care without pain or anxiety.

Dr. Leventer began his academic career in 1997 as a part time clinical instructor in Dental Anesthesiology at the University of Maryland School of Dentistry while maintaining a private general dental practice with a focus on anesthesia for dentistry. In 2009 he became a full time Clinical Assistant Professor at the University of Maryland School of Dentistry. He provides sedation and general anesthesia within the school of dentistry, practices general dentistry in the faculty practice and provides dental services at the University of Maryland Hospital. He has presented many CE courses on the topics of the use of sedation and anesthesia in dentistry.

This 2-hour course is structured as two credits towards the new eight-hour DEA requirement for any practitioner with a DEA license or new applicants for the same. The objective for this new DEA requirement, as per the DEA website, is to “promote understanding of SUDs as well as their identification, treatment, and management”.

In December 2022, the U.S. Congress passed an omnibus spending bill that included the Medication Access and Training Expansion (MATE) Act. This new law requires prescribers of controlled substances, including dentists, to complete eight hours of one-time training on safely prescribing controlled substances (Schedules II, III, IV, and/or V) in order to receive or renew their registration with the U.S. Drug Enforcement Administration (DEA).

This new requirement goes into effect on June 27, 2023.

This new DEA requirement is only a one-time training requirement.

This continuing dental education course is meant to aid dental practitioners in their understanding of the scope of substance use disorder, how it affects our community and how we can make a difference in decreasing its devastating effects. 

Outline:

1. Describe the background of the current opioid epidemic.
2. Describe what the DEA and FDA are doing to help decrease deaths from the opioid epidemic.
3. List commonly abused legal and illegal medications implicated in substance use disorder.
4. Describe the current accepted criteria for substance use disorder.
5. Understand how to use screening tools to help identify patients who may have a substance use disorder.
6. Describe the factors that predispose to substance use disorder.

This course is approved by the Maryland State Board of Dental Examiners.  This new 8 hour DEA requirement went into effect on June 27, 2023, is only a one-time training requirement.

After the completion of this course, the participants should:

• Have the knowledge, skills, and competencies to understand, recognize, refer, and treat patients with substance use disorders.
• Understand how to practice risk evaluation and mitigation strategies.

Upon completion of the online course, participants are required to pass an online post-course assessment with a minimum grade of 75%.

Once the online course has been accessed, no refunds will be provided.

Cancellation and Refund Policies